NASDAQ$ALHC
Alignment Healthcare Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Alignment Healthcare reported strong performance across its markets, exceeding guidance on key metrics.
Alignment Healthcare reported strong first-quarter results, exceeding guidance on membership, revenue, adjusted gross profit, and adjusted EBITDA. The company is focused on clinical excellence and member experience.
- First quarter results demonstrated robust performance across markets.
- Guidance was exceeded on four key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA.
- Clinical excellence is at the center of the member experience.
- Employees are committed to service.
Headline financials
Revenue & EPS history
Alignment Healthcare · Revenue · Quarterly
$439M
Revenue by segment
Alignment Healthcare · $265M total across 2 segments · Q1 2021
- Earned premiums$265M+18.0%100.0%
- Other revenue$82K—0.0%
Forward guidance
The release contains forward-looking statements regarding future growth and financial outlook for the quarter ending June 30, 2023, and year ending December 31, 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
+1.8%
Avg return
Earnings day
+1.8%
Avg return
5 days after
+2.6%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+27.0%
Q1 2024
Best reaction
-16.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -15.7% | -29.5% | |
| Q4 2025 | -5.8% | -7.5% | -18.6% | |
| Q3 2025 | -1.9% | -0.4% | +12.2% | |
| Q1 2025 | -7.7% | -7.5% | -8.3% | |
| Q4 2024 | +16.5% | +17.4% | +35.9% | |
| Q3 2024 | +1.6% | +12.2% | +11.2% | |
| Q2 2024 | +2.3% | +4.9% | +3.1% | |
| Q1 2024 | +27.0% | +31.6% | +51.0% | |
| Q4 2023 | -8.9% | -9.2% | -20.1% | |
| Q3 2023 | -9.6% | -7.2% | +10.5% | |
| Q2 2023 | +7.5% | +10.5% | -4.2% | |
| Q1 2023 | +3.5% | +11.3% | -5.1% | |
| Q4 2022 | -16.4% | -20.9% | -35.2% | |
| Q3 2022 | -3.1% | -3.3% | -2.7% | |
| Q2 2022 | +10.4% | +4.3% | -8.7% | |
| Q1 2022 | -7.0% | -18.8% | +6.8% | |
| Q4 2021 | +10.7% | +8.0% | +39.7% | |
| Q3 2021 | +10.6% | +6.1% | -26.7% | |
| Q2 2021 | -8.5% | -4.8% | -11.2% | |
| Q1 2021 | +6.8% | +13.3% | +27.6% | |
| Q4 2020 | +6.8% | +13.3% | +27.6% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro